Sr. Director, Global Brand & Portfolio Management

Job Summary:

The Sr. Director, Global Brand & Portfolio Management is accountable for defining and executing Seqirus's global portfolio vision and strategy across current influenza brands (inline), pipeline assets, and adjacent vaccine opportunities. This role leads a team responsible for global product portfolio strategy and positioning, global brand and lifecycle management, and new product planning and launch readiness. In partnership with cross-functional stakeholders, the role provides commercial and portfolio leadership to inform evidence generation priorities, pricing and market access strategies, and portfolio investments.

Working in close partnership with R&D and cross-functional stakeholders, the role ensures alignment from research through commercialization, advances high-value strategic investments, and drives portfolio decisions that maximize mid- to long-term growth, value creation, and public health impact. As a member of the Global Commercial Strategy & Planning (GCS&P) Leadership Team, the Sr. Director serves as a key strategic leader across the global vaccines organization.

This is a hybrid role, which offers a combination of an onsite and remote work schedule.  #LI-hybrid

Principal Accountabilities:

Global Portfolio Strategy & Brand Leadership In partnership with R&D and GCS&P’s External Partnerships team, lead the development and execution of Seqirus's global Portfolio Development Strategy (PDS), ensuring alignment with the broader Business Unit (BU) Strategy.

Partner with GCS&P’s Strategy & Business Planning team on development/evolution of aforementioned BU Strategy, including overseeing development of strategic imperatives and objectives as well as cross-functional tactical plans. Aim is to provide strategic oversight and vision for initiatives that create value and drive improvement for Seqirus.

Direct a team responsible for global product strategy across marketed vaccines, pipeline assets, and launch products.

Define product portfolio positioning, co-positioning strategies, above-brand narratives, evidence themes, lifecycle priorities, and portfolio investment recommendations.

Oversee lifecycle management strategies that drive both short- and long-term growth of commercialized brands.

Lead global launch planning and commercialization readiness for pipeline assets, including launch sequencing, business case development, and resource prioritization.

Oversees and guides continued global launch planning for aTIVc, including maximizing the portfolio opportunity across Fluad and aTIVc, refining the launch sequencing strategy, advancing business cases for key investments, and leveraging the Glocal brand marketing model (global to local division of activities) to drive efficiencies.

Direct geographic expansion strategies and evaluate market entry and exit opportunities across the portfolio.

Provide portfolio and commercial input into long-term pricing strategies, value propositions, and market access planning in partnership with Global Market Access & Pricing for both inline and pipeline products

Support evaluation of external partnerships, business development opportunities, and portfolio expansion opportunities which are led by GCS&P’s External Partnerships team.

Oversee development and continuous improvement of global claims, messaging, communications, and scientific narratives.

Ensure product portfolio strategies are informed by market research, competitive intelligence, customer insights, epidemiological trends, and evolving vaccine market dynamics.

Manage team budgets and identify opportunities to improve operational efficiency and return on investment.

Portfolio Development, Strategic Decision-Making & Governance Lead the commercial evaluation and strategic development of internal vaccine programs from early development through commercialization in partnership with R&D, GCS&P’s Strategy & Business Planning team, GCS&P’s External Partnerships team and various cross-functional team members.

Direct assessment of key development milestones, including clinical strategy, evidence requirements, comparator selection, timing, and commercial readiness.

Identify portfolio opportunities, risks,…